Kegan Zhu
Overview
Explore the profile of Kegan Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pan W, Han Y, Zhang M, Zhu K, Yang Z, Qiu M, et al.
Apoptosis
. 2025 Feb;
PMID: 39924586
Microplastics (MPs) are widely distributed environmental pollutants around the world. Although studies have demonstrated that MPs have adverse effects on human health, the relationship between MPs and tumors remains unclear....
2.
Yang H, Zhang H, Yang Y, Wang X, Deng T, Liu R, et al.
Theranostics
. 2024 Jun;
14(8):3081.
PMID: 38855172
[This corrects the article DOI: 10.7150/thno.44419.].
3.
Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu K, et al.
Oncogene
. 2023 Jul;
42(34):2591.
PMID: 37488195
No abstract available.
4.
Hu D, Zhou Z, Wang J, Zhu K
Front Mol Biosci
. 2022 Oct;
9:979854.
PMID: 36203871
Colorectal cancer (CRC) remains a common malignant tumor of digestive tract with high incidence rate and high mortality in the worldwide. The current clinical treatments of CRC often fail to...
5.
Bai M, Li J, Yang H, Zhang H, Zhou Z, Deng T, et al.
Mol Ther
. 2022 Jul;
30(7):2636.
PMID: 35797978
No abstract available.
6.
Yang H, Zhang H, Yang Y, Wang X, Deng T, Liu R, et al.
Theranostics
. 2022 Apr;
12(6):2635-2636.
PMID: 35401824
[This corrects the article DOI: 10.7150/thno.44419.].
7.
He Y, Zhang H, Zhang Y, Wang P, Zhu K, Ba Y
Int J Gen Med
. 2022 Apr;
15:3375-3391.
PMID: 35368798
Background: Stomach adenocarcinoma (STAD) ranks as the third leading cause of cancer death worldwide. TGF‑β receptor 1 (TGFBR1), serving important roles in the TGF‑β family, the mechanisms whereby TGFBR1 governs...
8.
Zhang H, Wang M, He Y, Deng T, Liu R, Wang W, et al.
Cell Death Dis
. 2021 Nov;
12(12):1116.
PMID: 34845198
Cancer stem cells (CSCs) are an important cause of tumor recurrence and drug resistance. As a new type of cell death that relies on iron ions and is strictly regulated...
9.
Li G, Lei X, Zhang Y, Liu Z, Zhu K
Front Oncol
. 2021 Nov;
11:761205.
PMID: 34746000
ALL (Acute lymphoblastic leukemia) is the most common pediatric malignancy and T-ALL (T-cell acute lymphoblastic leukemia) comprises about 15% cases. Compared with B-ALL (B-cell acute lymphoblastic leukemia), the prognosis of...
10.
Lin D, Zhang H, Liu R, Deng T, Ning T, Bai M, et al.
Mol Oncol
. 2021 Jul;
15(12):3430-3446.
PMID: 34213835
Fatty acid oxidation (FAO) plays a vital role in drug resistance in cancer cells. Carnitine palmitoyltransferase 1A (CPT1A), a key enzyme of FAO, is widely recognized as an emerging therapeutic...